Posted by Two Blokes
Much credit goes to large-caps for pulling the broad market out of April's sell-off abyss. But traders looking
Source: Two Blokes Trading
Posted by Two Blokes
Environmental, social, and governance (ESG) hasn't lost traction after exploding in popularity after the 2020
Source: Two Blokes Trading
Posted by Two Blokes
The crude oil market continues to see a lot of noisy trading, but overall, we are looking to go higher over th
Source: Two Blokes Trading
Posted by Two Blokes
BMY leans on Opdivo's solid growth and new approvals as generics pressure its other top drugs and shares remai
Source: Two Blokes Trading
Posted by Two Blokes
GSK is witnessing increased sales growth of its Specialty Medicines unit, a trend expected to continue through
Source: Two Blokes Trading
Posted by Two Blokes
VRNA jumps 20% after Merck unveils buyout to add COPD drug Ohtuvayre and reduce its reliance on Keytruda.
Source: Two Blokes Trading
Posted by Two Blokes
Wix teams up with Monotype to expand its font library, fueling creative freedom, as it bets on AI, Studio and
Source: Two Blokes Trading
Posted by Two Blokes
VLRS sees June traffic dip 1.4% despite a 0.6% capacity rise, pushing its load factor down to 83.9% from 85.6%
Source: Two Blokes Trading
Posted by Two Blokes
As EV adoption in China accelerates, the race to build faster, smarter and more accessible charging networks i
Source: Two Blokes Trading
Posted by Two Blokes
Amplify Energy shares are down approximately 50% due to a terminated merger and significant declines in oil an
Source: Two Blokes Trading
Posted by Two Blokes
Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring wha
Source: Two Blokes Trading
Posted by Two Blokes
SERV's Q1 revenues are aided by Gen 3 robot rollout, boosting deliveries and merchant growth across new market
Source: Two Blokes Trading